• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Clinical Outcomes of 402 Patients With COVID-2019 From a Single Center in Wuhan, China

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Jun 12.
doi: 10.1002/jmv.26168. Online ahead of print.
Clinical Outcomes of 402 Patients With COVID-2019 From a Single Center in Wuhan, China


Yingjie Wu[SUP] 1 [/SUP], Wei Guo[SUP] 1 2 [/SUP], Huan Liu[SUP] 1 [/SUP], Bei Qi[SUP] 1 [/SUP], Ke Liang[SUP] 3 [/SUP], Haibo Xu[SUP] 4 [/SUP], Zhiyong Peng[SUP] 5 [/SUP], Shu-Yuan Xiao[SUP] 1 6 [/SUP]



Affiliations

Abstract

The outbreak of SARS-CoV-2 has become a pandemic with significant mortality. Published studies describing clinical characteristics of the disease contain small cohorts from individual centers or larger series consisting of mixed series from multiple different hospitals. We report here analyses of mortality and disease severity among 402 patients from a single hospital. The cohort includes 297 patients with confirmed and 105 with clinical diagnosis. The latter group consists of cases with inconclusive nucleic acid test but meeting the criteria for clinical diagnosis. Data are compared between genders and among different age groups. The overall case fatality is 5.2%. However, age at 70 years or older is associated with a significantly higher mortality (17.8%) and higher rate of severe and critical illness (57.5%). Case fatality is 8% in patients 50 years of age or older, and 1.2% in those younger than 50 years. In addition, case fatality is 7.6% in male patients, as opposed to 2.9% in females, demonstrating a clear gender difference. This article is protected by copyright. All rights reserved.

Keywords: COVID-19; Coronavirus; SARS-CoV-2; diagnosis; epidemiology; fatality; mortality.
 
Back
Top Bottom